High placebo responses common in tests of neuropsychiatric drugs make any clinical trial in major depressive disorder risky. Intra-Cellular Therapies now has data showing its drug met key goals of a ...

November 25, 2008 — Fourteen drugs have been identified that most urgently require research regarding off-label uses, according to the results of a retrospective, cross-sectional study and ...

When prescription depression drugs fall short in efficacy, there’s an off-label way to help them work better: add-on doses of thyroid hormone. Clinicians have long known about this approach and some ...